Skip to content. | Skip to navigation

Sections
IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Find out more
Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Donate
Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.

Participate
 

ABC 7:30 Report on the APGI

Professor Andrew Biankin talks to the 7:30 Report about exciting new developments in pancreatic cancer research in Australia. Broadcast in April 2010.

ABC 7:30 Report on the APGI
© 2011 Australian Pancreatic Cancer Genome Initiative (APGI)
HOME  |  CONTACT US  |  SITEMAP
Site by Mooball IT
Personal tools
Log in